MIASTENIYA GRAVISDA MIKRONUTRIENTLAR VA MIKROELEMENTLAR DISREGULYATSIYASI: KLINIK DALILLAR, BIOLOGIK ASOSLAR VA TADQIQOTDAGI BO‘SHLIQLAR
DOI:
https://doi.org/10.5281/zenodo.22980641Keywords:
miasteniya gravis, mikronutrientlar, mikroelementlar, vitamin D, temir, rux, timus, magniy, kalsiyAbstract
Miasteniya gravis (MG) nerv-mushak uzatilishining autoimmun kasalligi bo‘lib, uning kechishida immun, metabolik va nutritiv omillarning o‘zaro ta’siriga qiziqish ortmoqda. Ushbu narrativ tanqidiy sharh MGda mikronutrient va mikroelement o‘zgarishlariga oid klinik dalillarni umumlashtiradi, bevosita inson ma’lumotlarini biologik gipotezalardan ajratadi va tadqiqot bo‘shliqlarini belgilaydi. Vitamin D eng ko‘p o‘rganilgan bo‘lib, ayrim kohortlarda uning past darajasi qayd etilgan, ammo sababiylik tasdiqlanmagan. Temirga oid ma’lumotlar oddiy tanqislikdan ko‘ra gomeostaz o‘zgarishini ko‘rsatadi. Tarixiy rux tadqiqotlari ayrim MG guruhlarida qondagi rux oshishi va timus-immun faolligi bilan bog‘liqlikni ko‘rsatgan. Kalsiy va magniy asosan nerv-mushak fiziologiyasi va davolash xavfsizligi nuqtai nazaridan muhim. Mavjud dalillar MG uchun universal mikronutrient yetishmovchiligi modelini tasdiqlamaydi; istiqboldagi ishlar mikronutrient profillarini yallig‘lanish, timus fenotipi, autoantitana holati, davolash ekspozitsiyasi va standart klinik natijalar bilan birga baholashi kerak.References
1. Gilhus, N. E. (2016). Myasthenia gravis. N Engl J Med, 375(26), 2570–2581. https://doi.org/10.1056/NEJMra1602678
2. Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., & Burns, T. M. (2019). Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30. doi:10.1038/s41572-019-0079-y. 41572–019. https://doi.org/10.1038/s41572-019-0079-y
3. Koneczny, I., & Herbst, R. (2019). Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture. Cells. 2019;8(7):671. doi:10.3390/cells8070671. https://doi.org/10.3390/cells8070671
4. Uçak, M. N. (2025). Arıtıcı Çolak G. Myasthenia gravis and nutrition. Front Nutr. 2025;12:1600508. doi:10.3389/ fnut.2025.1600508. https://doi.org/10.3389/
5. Bonaccorso, G. (2023). Myasthenia gravis and vitamin D serum levels: a systematic review and meta-analysis. CNS Neurol Disord Drug Targets, 22(5), 752–760. https://doi.org/10.2174/1871527321666220707111344
6. Li, K., Hou, L., Tan, Y., Huang, Y., Shi, J., Han, J., et al. (2022). Iron metabolism patterns in non-anemic patients with myasthenia gravis: a cross-sectional and follow-up study. Front Neurol. 2022;13:1060204. doi:10.3389/ fneur.2022.1060204. a cross-sectional and follow-up study. Front Neurol. https://doi.org/10.3389/
7. Licastro, F., Mocchegiani, E., Fabris, N., Rinaldi, R., Bontempo, G., Tonon, C., et al. (1997). Altered thymic endocrine activity along with impairments of peripheral zinc metabolism and T-lymphocyte populations are associated with myasthenia gravis: a follow-up study. J Neuroimmunol, 77(2), 153–160. https://doi.org/10.1016/S0165-
8. Askmark, H., Haggård, L., Nygren, I., Punga, A. R., & Vitamin, D. (2012). deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study. Eur J Neurol, 19(12), 1554–1560. https://doi.org/10.1111/j.1468-1331.2012.03773.x
9. Guan, Y., Lv, F., Meng, Y., Ma, D., Xu, X., Song, Y., et al. (2017). Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study. Osteoporos Int, 28(8), 2383–2390. https://doi.org/10.1007/s00198-017-4041-0
10. Kang, S. Y., Kang, J. H., Choi, J. C., Song, S. K., & Oh, J. H. (2018). Low serum vitamin D levels in patients with myasthenia gravis. J Clin Neurosci, 50, 294–297. https://doi.org/10.1016/j.jocn.2018.01.047
11. Justo, M. E., Aldecoa, M., Cela, E., & Leoni, J. (2021). González Maglio DH, Villa AM, et al. Low vitamin D serum levels in a cohort of myasthenia gravis patients in Argentina. Photochem Photobiol, 97(5), 1145–1149. https://doi.org/10.1111/php.13432
12. Fan, Y., Huang, H., Chen, X., Chen, Y., Zeng, X., Lin, F., & Chen, X. (2023). Causal effect of vitamin D on myasthenia gravis: a two-sample Mendelian randomization study. Front Nutr. 2023;10:1171830. doi:10.3389/fnut.2023.1171830. https://doi.org/10.3389/fnut.2023.1171830
13. Huang, P. (2023). The relationship between serum iron levels and AChR-Ab and IL-6 in patients with myasthenia gravis. Eur Rev Med Pharmacol Sci, 27(1), 98–102. https://doi.org/10.26355/eurrev_202301_30857
14. Li, K., Hou, L., Tan, Y., Huang, Y., Shi, J., Han, J., et al. (2023). Iron metabolism in non-anemic myasthenia gravis patients: a cohort study. J Neuroimmunol. 2023;375:578015. doi:10.1016/j.jneuroim.2023.578015. a cohort study. J Neuroimmunol. 2023;375:578015. doi:10. https://doi.org/10.1016/j.jneuroim.2023.578015
15. Uzawa, A., Akamine, H., Kojima, Y., Ozawa, Y., Yasuda, M., Onishi, Y., et al. (2021). High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis. J Neuroimmunol. 2021;358:577634. doi:10.1016/j. jneuroim.2021.577634. https://doi.org/10.1016/j
16. Mocchegiani, E., Giacconi, R., Muzzioli, M., Gasparini, N., Provinciali, L., Spazzafumo, L., & Licastro, F. (2000). Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6. Mech Ageing Dev, 117(1-3), 79–91. https://doi.org/10.1016/S0047-6374(00)00145-7
17. Kornfeld, P., Somlyo, A., & Osserman, K. E. (1969). Role of calcium in myasthenia gravis. Arch Neurol. 1969;21(5):466-.
18. doi:10.1001/archneur.1969.00480170038003.
19. Wirguin, I., Brenner, T., Shinar, E., & Argov, Z. (1990). Citrate-induced impairment of neuromuscular transmission in human and experimental autoimmune myasthenia gravis. Ann Neurol, 27(3), 328–330. https://doi.org/10.1002/
20. Nakata, M., Kuwabara, S., Kawaguchi, N., Takahashi, H., Misawa, S., Kanai, K., et al. (2007). Is excitation-contraction coupling impaired in myasthenia gravis? Clin Neurophysiol. 10.1016/j. clinph.2007.01.001. https://doi.org/10.1016/j
21. Imai, T., Tsuda, E., Hozuki, T., Yoshikawa, H., Yamauchi, R., Saitoh, M., et al. (2012). Contribution of anti-ryanodine receptor antibody to impairment of excitation-contraction coupling in myasthenia gravis. Clin Neurophysiol, 123(6), 1242–1247. https://doi.org/10.1016/j.clinph.2011.10.038
22. Masuda, M., Utsumi, H., Tanaka, S., Maeno, A., Yamamoto, M., Sugiyama, K., et al. (2018). Treatment of myasthenia gravis with high-dose cholinesterase inhibitors and calcineurin inhibitors caused spontaneous muscle cramps in patients. Clin Neuropharmacol, 41(5), 164–170. https://doi.org/10.1097/WNF.0000000000000295
23. Singh, P., Idowu, O., Malik, I., & Nates, J. L. (2015). Acute respiratory failure induced by magnesium replacement in a 62-year-old woman with myasthenia gravis. Tex Heart Inst J, 42(5), 495–497. https://doi.org/10.14503/THIJ-14-
24. Jessop, K. (2022). Intravenous magnesium sulfate inducing acute respiratory failure in a patient with myasthenia gravis. BMJ Case Rep. 2022;15(6). doi:10.1136/bcr-2022-250455. https://doi.org/10.1136/bcr-2022-250455
25. Boev, V. M., Burdakov, V. V., Fel’dman, A. G., Kolosova, N. I., Kazistova, T. M., & Raimov, A. G. (2002). [Ecological aspects of myasthenia gravis in the Orenburg region]. Gig Sanit. 2002;(5):44-47. PMID:12476834. 12476834.
26. Fel’dman, A. G. (2004). Ekologo-klinicheskoe znachenie mikroelementov v razvitii miastenii [Ecological and clinical significance of trace elements in the development of myasthenia gravis]. Dissertation abstract. Orenburg; 2004.
27. Adamczyk-Sowa, M., Bieszczad-Bedrejczuk, E., Galiniak, S., Rozmiłowska, I., Czyżewski, D., Bartosz, G., & Sadowska-Bartosz, I. (2017). Oxidative modifications of blood serum proteins in myasthenia gravis. J Neuroimmunol, 305, 145–153. https://doi.org/10.1016/j.jneuroim.2017.01.019
28. Peng, F., Deng, X., Zhou, Z., Jiang, Y., Yang, Y., Tan, F., et al. (2012). Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis. Neuroimmunomodulation, 19(1), 43–49. https://doi.org/10.1159/000327727
29. Hosokawa, S., Oyamaguchi, A., & Yoshida, O. (1991). Trace elements and plasmapheresis. Int J Artif Organs, 14(4), 242–245. https://doi.org/10.1177/039139889101400408
30. Narayanaswami, P., Sanders, D. B., Wolfe, G., Benatar, M., Cea, G., Evoli, A., et al. (2021). International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology, 96(3), 114–122. https://doi.org/10.1212/WNL.0000000000011124
31. Dardenne, M., Pléau, J. M., Nabarra, B., Lefrancier, P., Derrien, M., Choay, J., & Bach, J. F. (1982). Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci U S A, 79(17), 5370–5373. https://doi.org/10.1073/pnas.79.17.5370
32. Kurbonovich, A. M. (2025). INTEGRATING INFORMATION AND COMMUNICATION TECHNOLOGIES WITH DATA SCIENCE FOR THE DEVELOPMENT OF NATIONAL ECONOMIC SECTORS. Economics and Innovative Technologies, 13(4), 83-93.
33. Abdullaev, M., & Kungratov, I. (2026). FUNDAMENTAL METHODS FOR IDENTIFYING AI-GENERATED DATA IN ACADEMIC AND ONLINE PUBLICATIONS USING MACHINE LEARNING AND NLP MODELS. Innovation Science and Technology, 2(6).
34. Kungratov, I., & Jumayev, S. (2025). THE IMPACT OF ECONOMIC GROWTH ON UNEMPLOYMENT IN CENTRAL ASIA. Innovation Science and Technology, 1(11).

